24th International Workshop on Long-term Complications of HIV and SARS-CoV-2

项目摘要 随着抗逆转录病毒疗法(Art)的成功，共病现在是主要原因。 全球艾滋病毒携带者的死亡和残疾情况，包括中低位 收入国家(LMIC)。大型会议是科学交流的重要场所 艾滋病毒共病研究的最新进展，但更小、更私密的形式 强调讨论和网络对艾滋病毒共病的职业发展至关重要 调查人员。此外，还需要一个论坛，以便就后急性呼吸综合征问题进行科学交流。 新冠肺炎后遗症，一种鲜为人知的综合征，可能与病因相同 有艾滋病病毒共病的特征。我们的研讨会，现在已经是第24个年头了，并更名为国际 艾滋病毒和SARS-CoV-2长期并发症研讨会，提供200个国际 代表们有机会齐聚一堂，讨论 艾滋病毒共病和PASC研究，以一室两天的形式进行。全体演讲者是 来自艾滋病毒研究以外的知名专家或具有特定专业知识的艾滋病毒研究人员 合并症。高度互动的PASC圆桌会议，有2-3次迷你会谈，强调关键和 PASC发病机制和治疗中新出现的问题。摘要演示文稿 包括26次15分钟的演讲和一次海报会议，为研究人员提供了充足的机会 展示并获得对他们最新工作的反馈。有了这个R13，我们建议增强第24个 讲习班(11月5日/6日，纽约市)，目的如下：1)为 LMIC通过向LMIC研究人员提供旅行奖学金进行的最新艾滋病毒共病研究， 支持LMIC的一位国际公认的非传染性疾病专家作为 全体演讲人，并与国际培训方案联系，2)提供持续和 关于PASC的最新研究成果的讨论和传播的扩大论坛， 3)通过奖学金方案支持早期艾滋病毒共病和PASC调查人员 和一个职业发展工作室。通过为艾滋病毒共病和PASC提供“科学家园” 来自世界各地的研究人员，我们希望催化未来对艾滋病毒的研究努力 合并症和PASC，促进将研究成果转化为临床策略 这可以延长PLWH和COVID较长者的寿命和健康时间。

Project Summary With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including in low and middle income countries (LMIC). Large meetings are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. In addition, there is a need for a forum for scientific exchange regarding post-acute sequelae of COVID-19 (PASC), a poorly understood syndrome which may share pathogenic features with HIV comorbidities. Our workshop, now in its 24th year and renamed the International Workshop on Long-term Complications of HIV and SARS-CoV-2, provides <200 international delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity and PASC research in a one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. A highly interactive PASC roundtable, with 2-3 mini-talks, highlights critical and emerging issues in the pathogenesis and management of PASC. Abstract presentations including 26 15-minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 24th Workshop (November 5th/6th in New York City) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to provide a continued and expanded forum for discussion and dissemination of the latest research findings regarding PASC, 3) to support early-stage HIV Comorbidity and PASC investigators with a scholarship program and a Career Development Studio. By providing a “scientific home” to HIV Comorbidity and PASC investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and PASC and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH and those with long COVID.